Progress and challenges in developing a molecular diagnostic test for neurofibromatosis type 1

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

This work was supported by the Asociación de Afectados de Neurofibromatosis, and by research grants from the Fundación Mutua Madrileña and Fondo de Investigaciones Sanitarias (PI10/00536). The authors declare that these donations did not influence the content of this article in any way. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Writing assistance was utilized in the production of this manuscript, which was financed by the funding sources indicated above.